University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Growth hormone therapy may benefit protein metabolism in mitochondrial encephalomyopathy.

Carroll, PV, Umpleby, AM, Albany, E, Jackson, NC, Morgan-Hughes, JA, Sonksen, PH and Russell-Jones, DL (1997) Growth hormone therapy may benefit protein metabolism in mitochondrial encephalomyopathy. Clin Endocrinol (Oxf), 47 (1). pp. 113-117.

Full text not available from this repository.

Abstract

Mitochondrial encephalomyopathy is a genetic disorder for which there is at present no cure. Conventional treatment regimes may not be effective in preventing weight loss and muscle wasting in many patients. Recombinant human GH has been shown to have anabolic effects on protein metabolism and to reduce muscle wasting in various diseases. We have treated a patient known to have myoclonus, epilepsy with ragged red fibres (MERRF) with a high protein diet for 1 month followed by a high protein diet and GH therapy for 1 month. To assess the benefit of these treatments the patient underwent whole body protein turnover, myometric and body composition studies at baseline, following the high protein diet (100 g/day) and following GH therapy. Whole body protein synthesis (and protein breakdown) increased following a high protein intake and was further enhanced by treatment with GH and in a high protein diet. Body composition did not change significantly following treatment with either the high protein diet or GH but there was an improvement in muscle performance following GH treatment. Mitochondrial encephalomyopathy, a wasting disorder, may be a disease in which the known protein anabolic effect of GH may have a therapeutic benefit.

Item Type: Article
Authors :
NameEmailORCID
Carroll, PVUNSPECIFIEDUNSPECIFIED
Umpleby, AMUNSPECIFIEDUNSPECIFIED
Albany, EUNSPECIFIEDUNSPECIFIED
Jackson, NCn.jackson@surrey.ac.ukUNSPECIFIED
Morgan-Hughes, JAUNSPECIFIEDUNSPECIFIED
Sonksen, PHUNSPECIFIEDUNSPECIFIED
Russell-Jones, DLUNSPECIFIEDUNSPECIFIED
Date : July 1997
Uncontrolled Keywords : Body Composition, Combined Modality Therapy, Dietary Proteins, Growth Hormone, Humans, Insulin-Like Growth Factor I, Male, Middle Aged, Mitochondrial Encephalomyopathies, Muscle, Skeletal, Proteins
Related URLs :
Depositing User : Symplectic Elements
Date Deposited : 17 May 2017 09:32
Last Modified : 17 May 2017 14:43
URI: http://epubs.surrey.ac.uk/id/eprint/824116

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800